AES 2025

Skip to main content
NeuroPace, Inc
  • Patients
  • Providers
  • Corporate
  • Investors
  • nSight
  • PDMS
  • Take the Quiz
  • Clinical Trials
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Preliminary NAUTILUS Results
  • Hear from Patients
    • Patient Stories
    • How Data Helped
    • RNS Community Chat
  • Resources
    • Find a Center
    • RNS Community Chat
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Clinical Trials
    • Contact Us
  • Blog
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
  • Learn About the RNS System
    • Drug-Resistant Epilepsy
    • The RNS System
  • See if you Qualify
    • Take the Quiz
    • Find a Center
  • Preliminary NAUTILUS Results
  • Hear from Patients
    • Patient Stories
    • How Data Helped
    • RNS Community Chat
  • Resources
    • Find a Center
    • RNS Community Chat
    • Education (brochures, infographics, videos)
    • Helpful Links
    • Clinical Trials
    • Contact Us
  • Blog
  • Current Patients
    • Manuals
    • MRI Safety
    • How-to Videos
    • Living with the RNS System
    • Current Patient FAQ
Press enter to begin your search

Important Safety Information

The RNS® System at AES 2025

BOOTH #125 EXHIBIT HALL, DEC 5-9, ATLANTA, GA

Another seizure stopped
Another unstoppable day

NeuroPace Events at AES 2025

Transforming epilepsy care with the RNS System

  • Sun, Dec 7th, 2:30 - 3:30 p.m.
  • Product Theater - Exhibit Hall

Add to Calendar

Join us to explore the latest advancements in the RNS System.

See the latest on the NAUTILUS study,* the first-and-only randomized controlled trial of neuromodulation for IGE (idiopathic generalized epilepsy).

Get a first look at next-generation NeuroPace AI under development.

Martha Morrell, MD, FAES
Chief Medical Officer,
NeuroPace

Kate Davis, MD, MSc, FAES
Associate Professor of Neurology, University of Pennsylvania

Patricia Dugan, MD
Professor, Department of Neurology at NYU Grossman School of Medicine

*For the NAUTILUS Study: CAUTION Investigational device. Limited by United States law to investigational use for Idiopathic Generalized Epilepsy.

Shruti Agashe, MD Patrick Landazuri, MD Derek Southwell, MD, PhD

Stimulation With a strategy:
Latest advances in neuromodulation

  • Sun, Dec 7th, 6:00 - 8:00 p.m.
  • Sky Room | Atlanta, GA

Register

Join thought leaders for a dinner and discussion on how hypothesis-based neuromodulation strategies with the RNS System are advancing the treatment of epilepsy.

Featured Speakers:

Shruti Agashe, MD, MS Assistant Professor, Neurology and Neurosurgery

Patrick Landazuri, MD Associate Professor, Neurology and Neurosurgery

Derek Southwell, MD, PhD Associate Professor, Neurosurgery

Discover how RNS System therapy can strengthen your epilepsy practice

  • Sat, Dec 6th, 6:30 - 8:30 p.m.
  • Bulla Gastrobar, Atlanta, GA

Register

Join us for a conversation with expert providers on best practices for bringing the RNS System to your DRE patients.

Featured speakers:

Edward Maa, MD Medical Director of Epilepsy Services,
Swedish Medical Center

Soundarya Gowda, MD Associate Professor, Carilion Clinic
Attending Physician, HCA Neurological Associates

Screenshot of a tablet app

Navigating RNS System Programming

  • Epileptologist sessions

    Sat, Dec 6th, 12:30 p.m. and 3:30 p.m.
    Sun, Dec 7th, 12:30 p.m.
    Mon, Dec 8th, 10:30 a.m.

    APP sessions

    Sun, Dec 8, 2:30 pm
    Mon, Dec 9, 12:30 pm

  • Georgia World Conference Center,
    Exhibit Hall Office #O1150

Register

Expand your expertise and discover advanced techniques for delivering personalized patient care with the RNS System.

Fellows networking reception

  • Fri, Dec 5th, 6:00 - 7:30 p.m.
  • City Winery, Atlanta, GA

Register

Join us for a fun gathering where you can mingle with colleagues and Epilepsy Program Directors. Learn how RNS System iEEG data can be used to inform management of anti-seizure medications.

Martha Morrell, MD, FAES
Chief Medical Officer,
NeuroPace

Patricia Dugan, MD
Professor, Department of Neurology at NYU Grossman School of Medicine

Visit booth #125 in the Exhibit Hall

See what's next in epilepsy care.

Come explore new clinical data, hear the latest treatment strategies, or get a first look at NeuroPace AI tools under development.

Rx Only. The RNS System is an adjunctive therapy for adults with refractory, partial onset seizures with no more than 2 epileptogenic foci.
See important safety information at: www.neuropace.com/safety/. ©2025 NeuroPace, Inc. NeuroPace, the NeuroPace logo, and RNS are registered trademarks of NeuroPace, Inc. Mountain View, CA 94043. NP250137 Rev1 Date 2025-10

  • Safety Information
  • Legal
  • Privacy Policy
1-866-726-387624-hr Support Line

PATIENTS

  • Drug-Resistant Epilepsy
  • The RNS System
  • Hear from Patients
  • Is It Right for You?
  • Current Patients
  • Resources

PROVIDERS

  • Product
  • Clinical Benefits
  • Actionable Insights
  • Patient Selection
  • Education & Training
  • Resources

CORPORATE

  • In The News
  • Press Releases
  • Leadership
  • Careers
  • Contact Us
  • FCOI Procedure

  • PATIENTS

    Safety

  • PROVIDERS

    Legal

  • INVESTORS

    Privacy Policy

  • CORPORATE

1-866-726-3876 24-hr Support Line

© 2026 NeuroPace, Inc.

Step 1 of 7

14%
    The RNS System is for individuals 18 and older who have focal epilepsy and have tried two or more medications without finding seizure control.

  • Based on your answers, your patient might benefit from the RNS System.

    Get your profile and a list of questions to ask your doctor.

  • Unfortunately it appears your patient is not an appropriate candidate for the RNS® System at this time.

  • The RNS® System is intended for patients who have undergone diagnostic testing that localized no more than 2 epileptogenic foci.

    If your patient has not undergone diagnostic testing, search here to find a comprehensive epilepsy center that can evaluate your patient, including determining if the RNS System is right for them.

  • If you are interested in learning more about the RNS® System, you can have an RNS® System professional contact you by filling out the form below:

  • By filling out this form, you are agreeing to the terms of our privacy policy. This form is intended for US residents only.

    By clicking submit, you are agreeing to receive communications from NeuroPace. You can unsubscribe at any time.

    * Required fileds

Share your Story: Terms and conditions

By filling out the form and submitting your story (and/or photograph), you are agreeing to the following:

  1. NeuroPace may review the information and any photographs you provide for potential publication on our website.
  2. If NeuroPace decides to use your story, we will contact you and ask you to sign a release for a version of your story to be used on the NeuroPace website, Facebook, Instagram, Twitter and/or LinkedIn. Unless you sign the release, we will not publish the story, your name, or the photographs you provided.
  3. Regardless of whether we publish your story, we will add your name and e-mail address to the NeuroPace email list to hear from us about product updates, upcoming events and other relevant information. We will not sell your information to third parties. 
  4. Our use of your information is subject to our Privacy Policy, which you can access here.
neuropace logoLogo Header Menu
  • Patients
  • Providers
  • Corporate
  • Investors
  • nSight
  • PDMS
  • Take the Quiz
  • Clinical Trials